Skip to main content

Peer Review reports

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

Original Submission
14 Jun 2021 Submitted Original manuscript
23 Aug 2021 Reviewed Reviewer Report - Massimo Carlo Mauri
7 Sep 2021 Reviewed Reviewer Report
12 Oct 2021 Author responded Author comments - Ludong Bai
Resubmission - Version 2
12 Oct 2021 Submitted Manuscript version 2
26 Oct 2021 Author responded Author comments - Ludong Bai
Resubmission - Version 3
26 Oct 2021 Submitted Manuscript version 3
27 Oct 2021 Author responded Author comments - Ludong Bai
Resubmission - Version 4
27 Oct 2021 Submitted Manuscript version 4
17 Nov 2021 Reviewed Reviewer Report - Massimo Carlo Mauri
29 Nov 2021 Reviewed Reviewer Report
13 Dec 2021 Author responded Author comments - Ludong Bai
Resubmission - Version 5
13 Dec 2021 Submitted Manuscript version 5
17 Jan 2022 Reviewed Reviewer Report
18 Jan 2022 Reviewed Reviewer Report - Massimo Carlo Mauri
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
18 Jan 2022 Editorially accepted
8 Feb 2022 Article published 10.1186/s12888-022-03728-2

You can find further information about peer review here.

Back to article page